抗原-话题@MedSci

#抗原#

244篇内容 | 4313人围观

关注话题

话题活跃用户

#插入话题

插入图片

最新最热

[GetTopicListResponse(id=1623382, encodeId=71591623382fd, content=<a href='/topic/show?id=62a655263e9' target=_blank style='color:#2F92EE;'>#抗原#</a>, objectTitle=J Clin Oncol：优化成人急性淋巴细胞白血病患者的嵌合抗原受体T细胞治疗, objectType=article, longId=201430, objectId=394e2014304d, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=394e2014304d, replyNumber=0, likeNumber=73, createdTime=2020-10-02, rootId=0, userName=xiaoyeshuang, userId=f59b20519025, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=394e2014304d, moduleTitle=J Clin Oncol：优化成人急性淋巴细胞白血病患者的嵌合抗原受体T细胞治疗, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=394e2014304d)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1623381, encodeId=0b88162338174, content=<a href='/topic/show?id=62a655263e9' target=_blank style='color:#2F92EE;'>#抗原#</a>, objectTitle=Blood：外源性抗原成功显著增强免疫耗竭的HIV CAR T细胞扩增, objectType=article, longId=197420, objectId=30ec19e420e7, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=30ec19e420e7, replyNumber=0, likeNumber=67, createdTime=2020-07-14, rootId=0, userName=xiaoyeshuang, userId=f59b20519025, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=30ec19e420e7, moduleTitle=Blood：外源性抗原成功显著增强免疫耗竭的HIV CAR T细胞扩增, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=30ec19e420e7)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1623380, encodeId=0a9a1623380b0, content=<a href='/topic/show?id=62a655263e9' target=_blank style='color:#2F92EE;'>#抗原#</a>, objectTitle=Blood：GVHD预防方案中加入雷帕霉素可显著改善HLA抗原错配的HCT患者预后, objectType=article, longId=197417, objectId=d98819e41790, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=d98819e41790, replyNumber=0, likeNumber=59, createdTime=2020-07-14, rootId=0, userName=xiaoyeshuang, userId=f59b20519025, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=d98819e41790, moduleTitle=Blood：GVHD预防方案中加入雷帕霉素可显著改善HLA抗原错配的HCT患者预后, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=d98819e41790)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1623379, encodeId=64e916233e9d4, content=<a href='/topic/show?id=62a655263e9' target=_blank style='color:#2F92EE;'>#抗原#</a>, objectTitle=Clinica Chimica Acta：阿尔及利亚人群年龄相关前列腺特异抗原(PSA)参考值的建立, objectType=article, longId=196435, objectId=25bd1964350c, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=25bd1964350c, replyNumber=0, likeNumber=58, createdTime=2020-06-26, rootId=0, userName=xiaoyeshuang, userId=f59b20519025, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=25bd1964350c, moduleTitle=Clinica Chimica Acta：阿尔及利亚人群年龄相关前列腺特异抗原(PSA)参考值的建立, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=25bd1964350c)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1623378, encodeId=3c7116233e8b3, content=<a href='/topic/show?id=62a655263e9' target=_blank style='color:#2F92EE;'>#抗原#</a>, objectTitle=J Gastroenterology: 血清乙肝核心相关抗原可预测乙肝e抗原阴性患者的肝细胞癌的发生, objectType=article, longId=196261, objectId=4012196261c7, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=4012196261c7, replyNumber=0, likeNumber=80, createdTime=2020-06-24, rootId=0, userName=xiaoyeshuang, userId=f59b20519025, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=4012196261c7, moduleTitle=J Gastroenterology: 血清乙肝核心相关抗原可预测乙肝e抗原阴性患者的肝细胞癌的发生, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=4012196261c7)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1623377, encodeId=285416233e710, content=<a href='/topic/show?id=62a655263e9' target=_blank style='color:#2F92EE;'>#抗原#</a>, objectTitle=Blood：少数识别肿瘤相关抗原的T细胞可激发抗肿瘤反应, objectType=article, longId=195467, objectId=7da319546eaf, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=7da319546eaf, replyNumber=0, likeNumber=78, createdTime=2020-06-09, rootId=0, userName=xiaoyeshuang, userId=f59b20519025, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=7da319546eaf, moduleTitle=Blood：少数识别肿瘤相关抗原的T细胞可激发抗肿瘤反应, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=7da319546eaf)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1623376, encodeId=953916233e6b9, content=<a href='/topic/show?id=62a655263e9' target=_blank style='color:#2F92EE;'>#抗原#</a>, objectTitle=新型抗原提呈免疫细胞在呼吸道感染中起着至关重要的作用, objectType=article, longId=194051, objectId=acae194051c5, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=acae194051c5, replyNumber=0, likeNumber=44, createdTime=2020-05-14, rootId=0, userName=xiaoyeshuang, userId=f59b20519025, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=acae194051c5, moduleTitle=新型抗原提呈免疫细胞在呼吸道感染中起着至关重要的作用, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=acae194051c5)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1623375, encodeId=f66c16233e5dd, content=<a href='/topic/show?id=62a655263e9' target=_blank style='color:#2F92EE;'>#抗原#</a>, objectTitle=Cancer：医疗补助扩大后前列腺癌诊断时前列腺特异性抗原水平变化情况 , objectType=article, longId=193848, objectId=df811938489b, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=df811938489b, replyNumber=0, likeNumber=67, createdTime=2020-05-11, rootId=0, userName=xiaoyeshuang, userId=f59b20519025, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=df811938489b, moduleTitle=Cancer：医疗补助扩大后前列腺癌诊断时前列腺特异性抗原水平变化情况 , moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=df811938489b)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1623374, encodeId=981f16233e480, content=<a href='/topic/show?id=62a655263e9' target=_blank style='color:#2F92EE;'>#抗原#</a>, objectTitle=J Gastroenterology：血管性血友病因子抗原与血小板比率（VITRO）评分可预测肝硬化患者的肝失代偿和死亡率 , objectType=article, longId=193338, objectId=b2a819333808, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=b2a819333808, replyNumber=0, likeNumber=91, createdTime=2020-05-03, rootId=0, userName=xiaoyeshuang, userId=f59b20519025, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=b2a819333808, moduleTitle=J Gastroenterology：血管性血友病因子抗原与血小板比率（VITRO）评分可预测肝硬化患者的肝失代偿和死亡率 , moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=b2a819333808)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1623373, encodeId=0ee716233e335, content=<a href='/topic/show?id=62a655263e9' target=_blank style='color:#2F92EE;'>#抗原#</a>, objectTitle=Cancer Cell：癌王又一秘笈被破解！研究发现，肿瘤新抗原反倒会促进胰腺癌进展，增强树突状细胞功能可破解, objectType=article, longId=193220, objectId=196919322099, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=196919322099, replyNumber=0, likeNumber=80, createdTime=2020-05-01, rootId=0, userName=xiaoyeshuang, userId=f59b20519025, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=196919322099, moduleTitle=Cancer Cell：癌王又一秘笈被破解！研究发现，肿瘤新抗原反倒会促进胰腺癌进展，增强树突状细胞功能可破解, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=196919322099)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1623372, encodeId=78e816233e2fe, content=<a href='/topic/show?id=62a655263e9' target=_blank style='color:#2F92EE;'>#抗原#</a>, objectTitle=Prostate Cancer P D：共享决策和基于前列腺特异性抗原的前列腺癌筛查 , objectType=article, longId=193105, objectId=db55193105ab, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=db55193105ab, replyNumber=0, likeNumber=32, createdTime=2020-04-30, rootId=0, userName=xiaoyeshuang, userId=f59b20519025, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=db55193105ab, moduleTitle=Prostate Cancer P D：共享决策和基于前列腺特异性抗原的前列腺癌筛查 , moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=db55193105ab)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1623371, encodeId=6e9416233e108, content=<a href='/topic/show?id=62a655263e9' target=_blank style='color:#2F92EE;'>#抗原#</a>, objectTitle=Nat Commun：前列腺特异性抗原动态能够预测个体对间歇性雄激素阻断治疗的个体响应 , objectType=article, longId=192841, objectId=60cc192841a6, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=60cc192841a6, replyNumber=0, likeNumber=62, createdTime=2020-04-25, rootId=0, userName=xiaoyeshuang, userId=f59b20519025, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=60cc192841a6, moduleTitle=Nat Commun：前列腺特异性抗原动态能够预测个体对间歇性雄激素阻断治疗的个体响应 , moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=60cc192841a6)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1623370, encodeId=174716233e033, content=<a href='/topic/show?id=62a655263e9' target=_blank style='color:#2F92EE;'>#抗原#</a>, objectTitle=Clinica Chimica Acta：血浆癌抗原(CA)-125水平与导管消融术后房颤复发1年的关系如何？, objectType=article, longId=192156, objectId=5a8019215648, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=5a8019215648, replyNumber=0, likeNumber=58, createdTime=2020-04-14, rootId=0, userName=xiaoyeshuang, userId=f59b20519025, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=5a8019215648, moduleTitle=Clinica Chimica Acta：血浆癌抗原(CA)-125水平与导管消融术后房颤复发1年的关系如何？, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=5a8019215648)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1623369, encodeId=98211623369f3, content=<a href='/topic/show?id=62a655263e9' target=_blank style='color:#2F92EE;'>#抗原#</a>, objectTitle=Lancet：前列腺特异性膜抗原PET-CT用于高危前列腺癌患者分期, objectType=article, longId=190672, objectId=451b1906e214, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=451b1906e214, replyNumber=0, likeNumber=77, createdTime=2020-03-25, rootId=0, userName=xiaoyeshuang, userId=f59b20519025, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=451b1906e214, moduleTitle=Lancet：前列腺特异性膜抗原PET-CT用于高危前列腺癌患者分期, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=451b1906e214)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1623368, encodeId=194b162336859, content=<a href='/topic/show?id=62a655263e9' target=_blank style='color:#2F92EE;'>#抗原#</a>, objectTitle=CELL：SARS-CoV-2刺突糖蛋白的结构、功能和抗原性, objectType=article, longId=189832, objectId=c0e8189832e0, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=c0e8189832e0, replyNumber=0, likeNumber=136, createdTime=2020-03-13, rootId=0, userName=xiaoyeshuang, userId=f59b20519025, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=c0e8189832e0, moduleTitle=CELL：SARS-CoV-2刺突糖蛋白的结构、功能和抗原性, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=c0e8189832e0)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1623367, encodeId=47d1162336efc, content=<a href='/topic/show?id=62a655263e9' target=_blank style='color:#2F92EE;'>#抗原#</a>, objectTitle=Clinica Chimica Acta：CMV抗原特异性酶联免疫斑点法的建立的初步研究, objectType=article, longId=189120, objectId=835718912046, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=835718912046, replyNumber=0, likeNumber=63, createdTime=2020-03-03, rootId=0, userName=xiaoyeshuang, userId=f59b20519025, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=835718912046, moduleTitle=Clinica Chimica Acta：CMV抗原特异性酶联免疫斑点法的建立的初步研究, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=835718912046)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1623366, encodeId=eb2f1623366f5, content=<a href='/topic/show?id=62a655263e9' target=_blank style='color:#2F92EE;'>#抗原#</a>, objectTitle=J Hepatology：乙肝患者在接受糖皮质激素治疗后发生乙型肝炎表面抗原血清逆转的风险增加, objectType=article, longId=186944, objectId=e9791869445c, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=e9791869445c, replyNumber=0, likeNumber=73, createdTime=2020-01-31, rootId=0, userName=xiaoyeshuang, userId=f59b20519025, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=e9791869445c, moduleTitle=J Hepatology：乙肝患者在接受糖皮质激素治疗后发生乙型肝炎表面抗原血清逆转的风险增加, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=e9791869445c)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1623365, encodeId=67661623365c5, content=<a href='/topic/show?id=62a655263e9' target=_blank style='color:#2F92EE;'>#抗原#</a>, objectTitle=Int J Biol Sci：可溶性CD83能够通过调节抗原特异性Th2细胞特性来减轻试验性过敏性鼻炎, objectType=article, longId=186767, objectId=e56f186e67cb, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=e56f186e67cb, replyNumber=0, likeNumber=75, createdTime=2020-01-27, rootId=0, userName=xiaoyeshuang, userId=f59b20519025, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=e56f186e67cb, moduleTitle=Int J Biol Sci：可溶性CD83能够通过调节抗原特异性Th2细胞特性来减轻试验性过敏性鼻炎, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=e56f186e67cb)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1623364, encodeId=c740162336401, content=<a href='/topic/show?id=62a655263e9' target=_blank style='color:#2F92EE;'>#抗原#</a>, objectTitle=新研究预测到2030年，全球癌症新抗原疫苗市场将产生18.261亿美元的收入, objectType=article, longId=186456, objectId=7bd6186456ae, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=7bd6186456ae, replyNumber=0, likeNumber=52, createdTime=2020-01-19, rootId=0, userName=xiaoyeshuang, userId=f59b20519025, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=7bd6186456ae, moduleTitle=新研究预测到2030年，全球癌症新抗原疫苗市场将产生18.261亿美元的收入, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=7bd6186456ae)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1623363, encodeId=38c71623363b9, content=<a href='/topic/show?id=62a655263e9' target=_blank style='color:#2F92EE;'>#抗原#</a>, objectTitle=Sci Rep：良性前列腺增生生长过程中通过自身抗原识别的补体激活研究, objectType=article, longId=186439, objectId=a05e1864396c, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=a05e1864396c, replyNumber=0, likeNumber=79, createdTime=2020-01-18, rootId=0, userName=xiaoyeshuang, userId=f59b20519025, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=a05e1864396c, moduleTitle=Sci Rep：良性前列腺增生生长过程中通过自身抗原识别的补体激活研究, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=a05e1864396c)], followStatus=false, userIsMember=false, type=1, lengthMark=0)] 梅斯话题小助手

抗原

2020-05-29

xiaoyeshuang (审核中...)

前往app查看评论内容

#抗原#

J Clin Oncol：优化成人急性淋巴细胞白血病患者的嵌合抗原受体T细胞治疗

2020-10-02

xiaoyeshuang (审核中...)

前往app查看评论内容

#抗原#

Blood：外源性抗原成功显著增强免疫耗竭的HIV CAR T细胞扩增

2020-07-14

xiaoyeshuang (审核中...)

前往app查看评论内容

#抗原#

Blood：GVHD预防方案中加入雷帕霉素可显著改善HLA抗原错配的HCT患者预后

2020-07-14

xiaoyeshuang (审核中...)

前往app查看评论内容

#抗原#

Clinica Chimica Acta：阿尔及利亚人群年龄相关前列腺特异抗原(PSA)参考值的建立

2020-06-26

xiaoyeshuang (审核中...)

前往app查看评论内容

#抗原#

J Gastroenterology: 血清乙肝核心相关抗原可预测乙肝e抗原阴性患者的肝细胞癌的发生

2020-06-24

xiaoyeshuang (审核中...)

前往app查看评论内容

#抗原#

Blood：少数识别肿瘤相关抗原的T细胞可激发抗肿瘤反应

2020-06-09

xiaoyeshuang (审核中...)

前往app查看评论内容

#抗原#

新型抗原提呈免疫细胞在呼吸道感染中起着至关重要的作用

2020-05-14

xiaoyeshuang (审核中...)

前往app查看评论内容

#抗原#

Cancer：医疗补助扩大后前列腺癌诊断时前列腺特异性抗原水平变化情况

2020-05-11

xiaoyeshuang (审核中...)

前往app查看评论内容

#抗原#

J Gastroenterology：血管性血友病因子抗原与血小板比率（VITRO）评分可预测肝硬化患者的肝失代偿和死亡率

2020-05-03

xiaoyeshuang (审核中...)

前往app查看评论内容

#抗原#

Cancer Cell：癌王又一秘笈被破解！研究发现，肿瘤新抗原反倒会促进胰腺癌进展，增强树突状细胞功能可破解

2020-05-01

xiaoyeshuang (审核中...)

前往app查看评论内容

#抗原#

Prostate Cancer P D：共享决策和基于前列腺特异性抗原的前列腺癌筛查

2020-04-30

xiaoyeshuang (审核中...)

前往app查看评论内容

#抗原#

Nat Commun：前列腺特异性抗原动态能够预测个体对间歇性雄激素阻断治疗的个体响应

2020-04-25

xiaoyeshuang (审核中...)

前往app查看评论内容

#抗原#

Clinica Chimica Acta：血浆癌抗原(CA)-125水平与导管消融术后房颤复发1年的关系如何？

2020-04-14

xiaoyeshuang (审核中...)

前往app查看评论内容

#抗原#

Lancet：前列腺特异性膜抗原PET-CT用于高危前列腺癌患者分期

2020-03-25

xiaoyeshuang (审核中...)

前往app查看评论内容

#抗原#

CELL：SARS-CoV-2刺突糖蛋白的结构、功能和抗原性

2020-03-13

xiaoyeshuang (审核中...)

前往app查看评论内容

#抗原#

Clinica Chimica Acta：CMV抗原特异性酶联免疫斑点法的建立的初步研究

2020-03-03

xiaoyeshuang (审核中...)

前往app查看评论内容

#抗原#

J Hepatology：乙肝患者在接受糖皮质激素治疗后发生乙型肝炎表面抗原血清逆转的风险增加

2020-01-31

xiaoyeshuang (审核中...)

前往app查看评论内容

#抗原#

Int J Biol Sci：可溶性CD83能够通过调节抗原特异性Th2细胞特性来减轻试验性过敏性鼻炎

2020-01-27

xiaoyeshuang (审核中...)

前往app查看评论内容

#抗原#

新研究预测到2030年，全球癌症新抗原疫苗市场将产生18.261亿美元的收入

2020-01-19

xiaoyeshuang (审核中...)

前往app查看评论内容

#抗原#

Sci Rep：良性前列腺增生生长过程中通过自身抗原识别的补体激活研究

2020-01-18

科室
- - 订阅+
  - 更多科室
工具
服务